Viking Global Investors employs a multi-faceted investment strategy, primarily focusing on long/short equity, long-only equity, and private equity across global markets. Their approach is rooted in deep, fundamental research to identify high-quality companies with strong growth potential, often maintaining a diversified portfolio with a preference for technology and healthcare sectors.
33% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 4 prior). Average disclosed round size is $116.2M (across 31 rounds with reported amounts).
Portfolio
33
Fund Size
$57B
Top Stage
Series B
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
33 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| WWomen's Health, Sports & Performance Institute | Series C | $50M | Jan 2026 |
 Antheia | Series C | $56M | Jun 2025 |
 Triveni Bio Inc. | Series B | $115M | Oct 2024 |
| Antheia | Series A | $17M | Jul 2024 |
 AlphaSense | Growth | $650M | Jun 2024 |
 Diagonal Therapeutics | Series A | $128M | Apr 2024 |
 Human Immunology Biosciences (HI-Bio) | Series B | $95M | Jan 2024 |
 Solarea Bio | Series B | $15M | May 2023 |
| AlphaSense | Series D | $100M | Apr 2023 |
 Vector BioMed | Seed | — | Jan 2023 |
| DDock | Growth | $110M | May 2022 |
| GGlobal Processing Services | Growth | $300M | Oct 2021 |
 Arctic Wolf | Series F | $150M | Jul 2021 |
| EEcovative Design | Growth | $60M | Mar 2021 |
 ID.me | Series C | $100M | Mar 2021 |
 Amunix Pharmaceuticals, Inc. | Series B | $117M | Mar 2021 |
 HeadLight | Series B | $25.6M | Jun 2020 |
 Athira Pharma, Inc. | Series B | $85M | Jun 2020 |
 Ginkgo Bioworks | Series C | $70M | May 2020 |
| NNextGen Jane | Series A | $9M | Apr 2019 |
 Talkdesk | Series D | $100M | Oct 2018 |
 Checkerspot Inc. | Seed | $5M | Jun 2018 |
| BBirchbox | Series B | $60M | Apr 2014 |
| MMotif Ingredients | Series A | $90M | — |
 Joyn Bio | Series A | $100M | — |
Page 1 of 2
Top Co-Investors
Goldman Sachs3 shared
SoftBank Vision Fund2 shared
Goldman Sachs Alternatives2 shared
PSP Growth2 shared
Lead Edge Capital2 shared
WndrCo2 shared
Willoughby Capital2 shared
BoxGroup2 shared
Moonshots Capital2 shared
Atlas Venture2 shared
Riverwood Capital2 shared
Franklin Templeton2 shared
Janus Henderson Investors2 shared
Avidity Partners2 shared
Casdin Capital2 shared
Andreessen Horowitz2 shared
EDBI1 shared
In-Q-Tel1 shared
Civilization Ventures1 shared
Last updated: 5 March 2026